However, nausea and vomiting during attacks may limit the usefulness of oral medications. An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high ...
The collaboration is in line with Orexo's strategy to broaden the use of its powder-based drug delivery technology AmorphOX ®. Abera is a developer of mucosal vaccines and has several preclinical ...
Nanobiotechnology — the characterization, design and application of biological systems at the nanometre scale — is a rapidly evolving area at the crossroads of nanoscience, biology and ...
How can we help you? Explore the future of science and technology with our Nanotechnology and Nanoscience programme. Learn to design and develop innovative materials and devices at the nanoscale. Join ...
If you still have stuffiness after taking antibiotics, decongestants may help. Nasal sprays work faster than oral decongestants. Don't use them for longer than recommended, though. They can irritate ...
Post-nasal drip, also called upper airway cough syndrome (UACS), is a common disorder. It can be caused by colds, allergies, gastroesophageal reflux disease (GERD), and other conditions. It occurs ...
The vaccine candidates can be administered as nasal sprays and are fast and cost-effective to develop and produce. Using its platform technologies, the company has developed several vaccine ...
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China School of Chinese Materia Medica, Nanjing University of Chinese ...
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China School of Chinese Materia Medica, Nanjing University of Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback